Tricida, Inc. (TCDA) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 584 transactions totaling $313.6M, demonstrating a bearish sentiment with -$102.5M in net insider flow. The most recent transaction on Nov 25, 2022 involved a sale of 3,629,226 shares valued at $798.4K.
No significant insider buying has been recorded for TCDA in the recent period.
No significant insider selling has been recorded for TCDA in the recent period.
Based on recent SEC filings, insider sentiment for TCDA is bearish with an Insider Alignment Score of 34/100 and a net flow of -$102.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Tricida, Inc. (TCDA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading TCDA stock, having executed 584 transactions in the past 90 days. The most active insider is David P. Bonita (Executive), who has made 15 transactions totaling $81.3M.
Get notified when executives and directors at TCDA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | P. Bonita David | Executive | Sale | 3,629,226 | $0.22 | $798.4K | Large |
| Nov 25, 2022 | Llc Orbimed Advisors | Executive | Sale | 3,629,226 | $0.22 | $798.4K | Large |
| Nov 23, 2022 | J. Alpern Robert | Executive | Sale | 131,879 | $0.21 | $27.7K | |
| Nov 23, 2022 | P. Bonita David | Executive | Sale | 5,617,300 | $0.21 | $1.2M | Large |
| Nov 23, 2022 | Llc Orbimed Advisors | Executive | Sale | 5,617,300 | $0.21 | $1.2M | Large |
| Nov 22, 2022 | P. Bonita David | Executive | Sale | 1,034,421 | $0.22 | $227.6K | |
| Nov 22, 2022 | Llc Orbimed Advisors | Executive | Sale | 1,034,421 | $0.22 | $227.6K | |
| Nov 21, 2022 | J. Alpern Robert | Executive | Sale | 27,584 | $0.23 | $6.3K | |
| Oct 26, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Sale | 2,367,174 | $0.46 | $1.1M | Large |
| Oct 25, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Sale | 1,970,418 | $0.57 | $1.1M | Large |
| Oct 24, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Sale | 2,113,948 | $0.61 | $1.3M | Large |
| Oct 19, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Purchase | 70,100 | $11.25 | $788.6K | Large |
| Oct 19, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Purchase | 241,366 | $10.29 | $2.5M | Large |
| Oct 18, 2022 | Capital Partners Ii, L.p. Venrock Healthcare | Executive | Purchase | 40,400 | $11.98 | $484.0K | |
| Oct 17, 2022 | P. Shah Nimish | Executive | Purchase | 170,292 | $11.67 | $2.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 336 | $208.0M | 64.2% |
Purchase(P) | 75 | $105.5M | 32.6% |
Award(A) | 36 | $9.7M | 3.0% |
Exercise(M) | 98 | $566.0K | 0.2% |
Payment(F) | 6 | $85.6K | 0.0% |
Other(J) | 7 | $0 | 0.0% |
Gift(G) | 3 | $0 | 0.0% |
Conversion(C) | 23 | $0 | 0.0% |
Insider selling pressure at Tricida, Inc. has increased, with 35 insiders executing 584 transactions across all time. Total sales of $208.0M significantly outpace purchases of $105.5M, resulting in a net outflow of $102.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.